| Published Application/Species/Sample/Dilution | Reference | 
|---|
| immunohistochemistry - paraffin section; human; loading ...; fig 5cwestern blot; human; fig 5a
 | Kim B, Jeong Y, Wong M, Martin L. DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC-derived motor neurons with SOD1 mutations. Acta Neuropathol Commun. 2020;8:7 pubmed  publisher | 
| western blot; human; 1:200; loading ...; fig 1b
 | Chiang H, Zhang X, Li J, Zhao X, Chen J, Wang H, et al . BRCA1-associated R-loop affects transcription and differentiation in breast luminal epithelial cells. Nucleic Acids Res. 2019;47:5086-5099 pubmed  publisher | 
| western blot; human; loading ...; fig s5b
 | Liu Y, Cussiol J, Dibitetto D, Sims J, Twayana S, Weiss R, et al . TOPBP1Dpb11 plays a conserved role in homologous recombination DNA repair through the coordinated recruitment of 53BP1Rad9. J Cell Biol. 2017;216:623-639 pubmed  publisher | 
| immunohistochemistry; human; loading ...; fig 4b
 | Spriggs C, Laimins L. FANCD2 Binds Human Papillomavirus Genomes and Associates with a Distinct Set of DNA Repair Proteins to Regulate Viral Replication. MBio. 2017;8: pubmed  publisher | 
| western blot; human; fig s2
 | Hampp S, Kiessling T, Buechle K, Mansilla S, Thomale J, Rall M, et al . DNA damage tolerance pathway involving DNA polymerase ? and the tumor suppressor p53 regulates DNA replication fork progression. Proc Natl Acad Sci U S A. 2016;113:E4311-9 pubmed  publisher | 
| immunohistochemistry - paraffin section; human; 1:100; fig s2a
 | Korlimarla A, Prabhu J, Remacle J, Rajarajan S, Raja U, C E A, et al . Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast Cancer. PLoS ONE. 2016;11:e0153113 pubmed  publisher | 
| immunohistochemistry - paraffin section; human; 0.1 mg/ml; fig s1
 | Scalia C, Gendusa R, Cattoretti G. A 2-Step Laemmli and Antigen Retrieval Method Improves Immunodetection. Appl Immunohistochem Mol Morphol. 2016;24:436-46 pubmed  publisher | 
| western blot; human; fig 6
 | Butin Israeli V, Adam S, Jain N, Otte G, Neems D, Wiesmüller L, et al . Role of lamin b1 in chromatin instability. Mol Cell Biol. 2015;35:884-98 pubmed  publisher | 
| immunocytochemistry; humanwestern blot; human
 | Xu H, Xian J, Viré E, McKinney S, Wei V, Wong J, et al . Up-regulation of the interferon-related genes in BRCA2 knockout epithelial cells. J Pathol. 2014;234:386-97 pubmed  publisher | 
|  | Tokunaga E, Fujita A, Takizawa K, Baba K, Akiyoshi S, Nakamura Y, et al . CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy. Breast Cancer. 2019;26:47-57 pubmed  publisher | 
|  | Hodgson D, Dougherty B, Lai Z, Fielding A, Grinsted L, Spencer S, et al . Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes. Br J Cancer. 2018;119:1401-1409 pubmed  publisher | 
|  | Nacson J, Krais J, Bernhardy A, Clausen E, Feng W, Wang Y, et al . BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance. Cell Rep. 2018;24:3513-3527.e7 pubmed  publisher | 
|  | Seo A, Steinberg Shemer O, Unal S, Casadei S, Walsh T, Gumruk F, et al . Mechanism for survival of homozygous nonsense mutations in the tumor suppressor gene BRCA1. Proc Natl Acad Sci U S A. 2018;115:5241-5246 pubmed  publisher | 
|  | Daniels S, Burghel G, Chambers P, Al Baba S, Connley D, Brock I, et al . Levels of DNA Methylation Vary at CpG Sites across the BRCA1 Promoter, and Differ According to Triple Negative and "BRCA-Like" Status, in Both Blood and Tumour DNA. PLoS ONE. 2016;11:e0160174 pubmed  publisher | 
|  | Wang Y, Krais J, Bernhardy A, Nicolas E, Cai K, Harrell M, et al . RING domain-deficient BRCA1 promotes PARP inhibitor and platinum resistance. J Clin Invest. 2016;126:3145-57 pubmed  publisher | 
|  | Nagy Z, Kalousi A, Furst A, Koch M, Fischer B, Soutoglou E. Tankyrases Promote Homologous Recombination and Check Point Activation in Response to DSBs. PLoS Genet. 2016;12:e1005791 pubmed  publisher | 
|  | Fleury H, Communal L, Carmona E, Portelance L, Arcand S, Rahimi K, et al . Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease. Genes Cancer. 2015;6:378-398 pubmed | 
|  | Santivasi W, Wang H, Wang T, Yang Q, Mo X, Brogi E, et al . Association between cytosolic expression of BRCA1 and metastatic risk in breast cancer. Br J Cancer. 2015;113:453-9 pubmed  publisher | 
|  | Goldstein M, Kastan M. Repair versus Checkpoint Functions of BRCA1 Are Differentially Regulated by Site of Chromatin Binding. Cancer Res. 2015;75:2699-707 pubmed  publisher | 
|  | Gu Y, Bouwman P, Greco D, Saarela J, Yadav B, Jonkers J, et al . Suppression of BRCA1 sensitizes cells to proteasome inhibitors. Cell Death Dis. 2014;5:e1580 pubmed  publisher | 
|  | Pickholtz I, Saadyan S, Keshet G, Wang V, Cohen R, Bouwman P, et al . Cooperation between BRCA1 and vitamin D is critical for histone acetylation of the p21waf1 promoter and growth inhibition of breast cancer cells and cancer stem-like cells. Oncotarget. 2014;5:11827-46 pubmed | 
|  | Acharya S, Kaul Z, Gocha A, Martinez A, Harris J, Parvin J, et al . Association of BLM and BRCA1 during Telomere Maintenance in ALT Cells. PLoS ONE. 2014;9:e103819 pubmed  publisher | 
|  | Renaud E, Rosselli F. FANC pathway promotes UV-induced stalled replication forks recovery by acting both upstream and downstream Pol? and Rev1. PLoS ONE. 2013;8:e53693 pubmed  publisher |